CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C01004 | BRD-A41145729 | methoprene-acid | RXRA | Retinoid receptor agonist | -- | Details |
| C01005 | BRD-A41199690 | BRD-A41199690 | -- | -- | -- | Details |
| C01006 | BRD-A41208012 | BRD-A41208012 | -- | -- | -- | Details |
| C01007 | BRD-A41228941 | BRD-A41228941 | -- | -- | -- | Details |
| C01008 | BRD-A41250203 | GP-42 | -- | -- | -- | Details |
| C01009 | BRD-A41250306 | cyclopenthiazide | -- | -- | -- | Details |
| C01010 | BRD-A41301928 | bongkrek-acid | SLC25A4 | Mitochondrial ADP, ATP translocase inhibitor | -- | Details |
| C01011 | BRD-A41304429 | practolol | ADRB1 | Adrenergic receptor antagonist | -- | Details |
| C01012 | BRD-A41316391 | BRD-A41316391 | -- | -- | -- | Details |
| C01013 | BRD-A41450521 | tosufloxacin | -- | -- | -- | Details |
| C01014 | BRD-A41451487 | PK-11195 | TSPO | Benzodiazepine receptor antagonist | -- | Details |
| C01015 | BRD-A41519720 | ezetimibe | NPC1L1 | Cholesterol inhibitor; Niemann-Pick C1-like 1 protein antagonist | -- | Details |
| C01016 | BRD-A41555725 | chlortetracycline | -- | -- | -- | Details |
| C01017 | BRD-A41630653 | BRD-A41630653 | SIGMAR1; SLC6A4 | Glutamate receptor antagonist | -- | Details |
| C01018 | BRD-A41649729 | BRD-A41649729 | -- | -- | -- | Details |
| C01019 | BRD-A41692738 | TGX-221 | PIK3CB | PI3K inhibitor | -- | Details |
| C01020 | BRD-A41722204 | sulmazole | -- | -- | -- | Details |
| C01021 | BRD-A41833852 | naloxone | OPRD1; OPRK1; OPRM1 | Opioid receptor antagonist | -- | Details |
| C01022 | BRD-A41916216 | BRD-A41916216 | -- | -- | -- | Details |
| C01023 | BRD-A41941932 | vitexin | -- | -- | -- | Details |
| C01024 | BRD-A41986761 | BRD-A41986761 | -- | -- | -- | Details |
| C01025 | BRD-A41995253 | brucine | -- | -- | -- | Details |
| C01026 | BRD-A41997916 | BRD-A41997916 | -- | -- | -- | Details |
| C01027 | BRD-A42030853 | BRD-A42030853 | -- | -- | -- | Details |
| C01028 | BRD-A42031983 | VU-0415555-1 | -- | -- | -- | Details |
| C01029 | BRD-A42153648 | formestane | CYP19A1 | Aromatase inhibitor | -- | Details |
| C01030 | BRD-A42167015 | carteolol | ADRB1; ADRB2 | Adrenergic receptor antagonist | -- | Details |
| C01031 | BRD-A42187224 | BRD-A42187224 | -- | -- | -- | Details |
| C01032 | BRD-A42246453 | BRD-A42246453 | -- | -- | 1-Ethylamino-3-(3-ethylamino-2-hydroxy-propoxy)-propan-2-ol | Details |
| C01033 | BRD-A42264566 | EHPG-piperazine | -- | -- | ehpg-piperazine | Details |
| C01034 | BRD-A42270467 | tenatoprazole | IDO1 | ATPase inhibitor | -- | Details |
| C01035 | BRD-A42335949 | alexidine | PTPMT1 | Phosphatidylglycerophosphatase inhibitor | -- | Details |
| C01036 | BRD-A42346008 | metanephrine | -- | -- | -- | Details |
| C01037 | BRD-A42383464 | actinomycin-d | -- | -- | -- | Details |
| C01038 | BRD-A42423104 | benproperine | -- | -- | -- | Details |
| C01039 | BRD-A42433574 | BRD-A42433574 | -- | -- | -- | Details |
| C01040 | BRD-A42536341 | BRD-A42536341 | -- | -- | -- | Details |
| C01041 | BRD-A42553870 | L-152804 | NPY5R | Neuropeptide receptor antagonist | -- | Details |
| C01042 | BRD-A42556028 | 1B | -- | -- | -- | Details |
| C01043 | BRD-A42571354 | cetirizine | HRH1 | Histamine receptor antagonist | -- | Details |
| C01044 | BRD-A42579861 | BRD-A42579861 | -- | -- | -- | Details |
| C01045 | BRD-A42610307 | BRD-A42610307 | -- | -- | -- | Details |
| C01046 | BRD-A42612443 | BRD-A42612443 | -- | -- | -- | Details |
| C01047 | BRD-A42628519 | iopanoic-acid | -- | -- | -- | Details |
| C01048 | BRD-A42649439 | triciribine | AKT3; AKT1; AKT2 | Akt inhibitor | -- | Details |
| C01049 | BRD-A42699921 | teriflunomide | DHODH | Dihydroorotate dehydrogenase inhibitor | -- | Details |
| C01050 | BRD-A42737819 | BRD-A42737819 | -- | -- | -- | Details |
| C01051 | BRD-A42759514 | ornidazole | -- | -- | -- | Details |
| C01052 | BRD-A42831637 | BRD-A42831637 | -- | -- | tetrahydrocannabinol-7-oic-acid | Details |
| C01053 | BRD-A42966393 | BRD-A42966393 | -- | -- | -- | Details |
| C01054 | BRD-A42969626 | BRD-A42969626 | -- | -- | -- | Details |
| C01055 | BRD-A42994615 | BRD-A42994615 | -- | -- | -- | Details |
| C01056 | BRD-A43076080 | BRD-A43076080 | -- | -- | -- | Details |
| C01057 | BRD-A43082555 | loxoprofen | -- | -- | -- | Details |
| C01058 | BRD-A43087975 | BRD-A43087975 | -- | -- | -- | Details |
| C01059 | BRD-A43126523 | BRD-A43126523 | -- | -- | -- | Details |
| C01060 | BRD-A43135847 | BRD-A43135847 | -- | -- | -- | Details |
| C01061 | BRD-A43150328 | penicillic-acid | -- | -- | -- | Details |
| C01062 | BRD-A43155244 | BRD-A43155244 | -- | -- | -- | Details |
| C01063 | BRD-A43164341 | BRD-A43164341 | -- | -- | -- | Details |
| C01064 | BRD-A43188678 | BRD-A43188678 | -- | -- | -- | Details |
| C01065 | BRD-A43210826 | BRD-A43210826 | -- | -- | -- | Details |
| C01066 | BRD-A43286952 | BRD-A43286952 | -- | -- | ethinyl-estradiol | Details |
| C01067 | BRD-A43330902 | BRD-A43330902 | -- | -- | -- | Details |
| C01068 | BRD-A43331270 | niguldipine | ADRA1A; CACNA1C | Calcium channel blocker; Adrenergic receptor antagonist | -- | Details |
| C01069 | BRD-A43392971 | monocrotaline | -- | -- | -- | Details |
| C01070 | BRD-A43409498 | BRD-A43409498 | -- | -- | -- | Details |
| C01071 | BRD-A43505851 | BRD-A43505851 | -- | -- | -- | Details |
| C01072 | BRD-A43575461 | BRD-A43575461 | -- | -- | -- | Details |
| C01073 | BRD-A43640821 | BRD-A43640821 | -- | -- | -- | Details |
| C01074 | BRD-A43671941 | oxprenolol | ADRB1 | Adrenergic receptor antagonist | -- | Details |
| C01075 | BRD-A43673346 | clindamycin | -- | -- | -- | Details |
| C01076 | BRD-A43805296 | BRD-A43805296 | -- | -- | -- | Details |
| C01077 | BRD-A43809092 | clobutinol | -- | -- | -- | Details |
| C01078 | BRD-A43849199 | karakoline | -- | -- | -- | Details |
| C01079 | BRD-A43882281 | pinacidil | ABCC9; ABCC8 | ATP channel activator; Potassium channel activator | -- | Details |
| C01080 | BRD-A43885598 | SID-7969543 | NR5A1 | Steroidogenic factor antagonist | -- | Details |
| C01081 | BRD-A43930669 | L-368899 | OXTR | Oxytocin receptor antagonist | -- | Details |
| C01082 | BRD-A43940795 | tetrahydropalmatine | -- | -- | -- | Details |
| C01083 | BRD-A43974499 | reboxetine | SLC6A2 | Adrenergic receptor antagonist | -- | Details |
| C01084 | BRD-A43974575 | tranylcypromine | KDM1A; MAOA; MAOB | Monoamine oxidase inhibitor | -- | Details |
| C01085 | BRD-A43999749 | homatropine-methylbromide | CHRM5 | Acetylcholine receptor antagonist | -- | Details |
| C01086 | BRD-A44008656 | doxylamine | HRH1 | Histamine receptor antagonist | -- | Details |
| C01087 | BRD-A44046220 | BRD-A44046220 | -- | -- | -- | Details |
| C01088 | BRD-A44068497 | BRD-A44068497 | -- | -- | -- | Details |
| C01089 | BRD-A44090213 | indoprofen | PTGS1; PTGS2 | Cyclooxygenase inhibitor; Prostanoid receptor antagonist | -- | Details |
| C01090 | BRD-A44133049 | azasetron | HTR3A | Serotonin receptor antagonist | -- | Details |
| C01091 | BRD-A44174994 | BRD-A44174994 | -- | -- | -- | Details |
| C01092 | BRD-A44244100 | BRD-A44244100 | -- | -- | -- | Details |
| C01093 | BRD-A44251274 | BRD-A44251274 | -- | -- | -- | Details |
| C01094 | BRD-A44438286 | BRD-A44438286 | -- | -- | -- | Details |
| C01095 | BRD-A44448661 | pentobarbital | GABRA1; GABRA2; GABRA3; GABRA4; GABRA5; GABRA6; GABRB1; GABRB2; GABRB3; GABRD; GABRE; GABRG1; GABRG2; GABRG3; GABRP; GABRQ | GABA receptor modulator; Barbiturate antiepileptic | -- | Details |
| C01096 | BRD-A44551378 | LFM-A12 | EGFR | EGFR inhibitor | -- | Details |
| C01097 | BRD-A44701612 | BRD-A44701612 | -- | -- | dihydroergocristine | Details |
| C01098 | BRD-A44780397 | mifepristone | NR3C1; AR; PGR | Progesterone receptor antagonist; Glucocorticoid receptor antagonist | -- | Details |
| C01099 | BRD-A44827100 | erythromycin | MLNR | NFKB pathway inhibitor | -- | Details |
| C01100 | BRD-A44862234 | BRD-A44862234 | -- | -- | -- | Details |
| C01101 | BRD-A44863528 | proglumide | CCKAR; CCKBR | CCK receptor antagonist | -- | Details |
| C01102 | BRD-A44990218 | BRD-A44990218 | -- | -- | -- | Details |
| C01103 | BRD-A45014336 | BRD-A45014336 | -- | -- | -- | Details |